MarketLooks, from MarketResearch.com, are concise 15-30 page summaries of popular full-length market research reports published by Kalorama Information. This MarketLooks report has been compiled from the following full-length study:
Title: The Worldwide Market for Prescription Generic Drugs- 4th Ed. published in November 2002
Each MarketLooks report includes top-level findings from the respective parent report in a rich, easy to read format accompanied by select charts and graphs. Reports published prior to July 2001 are delivered in Powerpoint™. Reports published after July 2001 are delivered in Adobe PDF™ format. All are available via Instant Online Delivery to allow you to use the valuable information you've purchased immediately.
MarketLooks covering Kalorama Information studies are the perfect answer for:
The busy executive, researcher or product manager who needs top line statistics today in an easy to read, easy to digest format
The busy information professional who regularly juggles a multitude of basic requests for high-level market information from information patrons.
The consultant or analyst who needs to ramp up on a new market or demographic area quickly
Abstract excerpts from full report:
The worldwide prescription generic drug market has evolved into a formidable and important participant in the complex world of healthcare. Generic drug manufacturers are poised for strong growth in the future as patent protection for a host of major pharmaceuticals are due to expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. Although the generic industry has stagnated since the late 1990s, that could change directly and the outlook for generic promotion is favorable in the next five years.
The landscape of generic companies is changing. Traditionally, generic companies developed a broad range of products that were easily manufactured, low-cost, and undifferentiated in the marketplace. However, a new breed of generic company is emerging, which will likely bring a greater threat to brand manufacturers than ever before. Many generic companies are using increased revenue generated from generic versions of a growing number of top-selling branded drugs to explore new drug targets, including specialty generics, generics with a distinction, generic biologicals, and proprietary molecules. Generic manufacturers have also been able to cross over into the brand name domain by establishing a foothold in specialty therapeutic areas.